Home/Pipeline/Ophthalmic APIs

Ophthalmic APIs

Eye Diseases

ApprovedCommercial

Key Facts

Indication
Eye Diseases
Phase
Approved
Status
Commercial
Company

About ChemWerth

Established in 1982 by Peter Werth, ChemWerth is a family-owned, global leader in the generic API sector, offering end-to-end services from product development to commercial supply. The company leverages exclusive partnerships with over 30 manufacturing facilities across the U.S., Europe, India, and China, and boasts a track record of over 550 worldwide regulatory approvals. Its core value proposition is enabling customers to reach the market faster through integrated technical, analytical, and regulatory support, with a focus on complex molecules, oncologicals, and antibiotics.

View full company profile